Nanotech Investing Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
Nanotech Investing Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
Nanotech Investing Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome , a Rare Pediatric Congenital Heart Defect
Nanotech Investing Longeveron® to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
Nanotech Investing George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors
Nanotech Investing Longeveron® to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa
Nanotech Investing Longeveron® to Present at the H.C. Wainwright 27th Annual Global Investment Conference
nanotech investing Longeveron® Announces Contract Development and Manufacturing Business and First Contract
nanotech investing Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Goldgroup Enters Into Agreement To Sell Subsidiary Minera Apolo, S.A. de C.V., Disposing of Pinos Project
